Page last updated: 2024-11-07

florfenicol amine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID156406
SCHEMBL ID2186436
MeSH IDM0221706

Synonyms (24)

Synonym
florfenicol amine
(1r,2s)-2-amino-3-fluoro-1-(4-methylsulfonylphenyl)propan-1-ol
sch-40458
76639-93-5
benzenemethanol, alpha-(1-amino-2-fluoroethyl)-4-(methylsulfonyl)-, (r-(r*,s*))-
AKOS017343690
(1r,2s)-1-[4-(methylsulfonyl)phenyl]-2-amino-3-fluoro-1-propanol
XLSYLQDVLAXIKK-NXEZZACHSA-N
(1r,2 s)-2-amino-3-fluoro-1-(4-methylsulfonylphenyl)-1-propanol
(1r,2s)-2-amino-3-fluoro-1-(4-methylsulfonylphenyl)-1-propanol
DTXSID30227460
SCHEMBL2186436
(1r,2s)-2-amino-3-fluoro-1-[4-methanesulfonyl)phenyl]-1-propanol
mfcd19704818
florfenicol amine, vetranal(tm), analytical standard
benzenemethanol, ?-(1-amino-2-fluoroethyl)-4-(methylsulfonyl)-, [r-(r*,s*)]-; (?r)-?-[(1s)-1-amino-2-fluoroethyl]-4-(methylsulfonyl)benzenemethanol; (1r,2s)-2-amino-3-fluoro-1-[4-methanesulfonyl)phenyl]-1-propanol; florfenicol amine; sch 40458
florfenicol-amine
rel-(1r,2s)-2-amino-3-fluoro-1-(4-(methylsulfonyl)phenyl)propan-1-ol
105182-37-4
HY-133695
CS-0129356
E87790
(alphar)-alpha-[(1s)-1-amino-2-fluoroethyl]-4-(methylsulfonyl)benzenemethanol
(1r,2s)-2-amino-3-fluoro-1-(4-(methylsulfonyl)phenyl)propan-1-ol

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" florfenicol injection (as a bolus), the terminal half-life (t(1/2)), the volume of distribution at steady state (V(dss)), and total body clearance were 11."( Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in the Korean catfish (Silurus asotus).
Kim, MS; Lim, JH; Park, BK; Yun, HI, 2006
)
0.58
" The maximum concentrations (Cmax , μg g(-1) or μg mL(-1) ) in plasma and tissues were observed at 2-6 h (the time to reach maximum concentration, Tmax ) except for bile (Tmax  = 24 h) and were in the order of intestine (52."( Pharmacokinetics of florfenicol and behaviour of its metabolite florfenicol amine in orange-spotted grouper (Epinephelus coioides) after oral administration.
Dong, JD; Feng, JB; Huang, DR; Liu, P; Zhong, M, 2016
)
0.67
" This study aimed to develop a population physiologically based pharmacokinetic (PBPK) model to predict the concentrations of FF and its metabolite, florfenicol amine (FFA), in cattle after four different routes of administration, and to calculate and compare the withdrawal intervals (WDIs) with approved withdrawal times based on different marker residues and their MRLs or tolerances."( Development and application of a population physiologically based pharmacokinetic model for florfenicol and its metabolite florfenicol amine in cattle.
Baynes, RE; Lin, Z; Riviere, JE; Yang, F, 2019
)
0.92
" Pharmacokinetic parameters were calculated using non-compartmental analysis."( Pharmacokinetics, tissue residue depletion, and withdrawal interval estimations of florfenicol in goats following repeated subcutaneous administrations.
Chen, Q; Clapham, MO; Davis, JL; Lin, Z; Tell, LA; Toney, E; Wetzlich, SE; Wu, X, 2023
)
0.91

Bioavailability

ExcerptReferenceRelevance
" administration of florfenicol, the t(1/2), C(max), t(max) and oral bioavailability (F) were 15."( Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in the Korean catfish (Silurus asotus).
Kim, MS; Lim, JH; Park, BK; Yun, HI, 2006
)
0.58
"A study on the bioavailability and pharmacokinetics of florfenicol was conducted in six healthy dogs following a single intravenous (i."( Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Hwang, YH; Kim, MS; Lim, JH; Park, BK; Yun, HI, 2008
)
0.6
" Oral bioavailability was found to be 87 +/- 16%."( Plasma and tissue depletion of florfenicol and florfenicol-amine in chickens.
Anadón, A; Ares, I; Caballero, V; Martínez, M; Martínez, MA; Martínez-Larrañaga, MR; Ríos, A, 2008
)
0.35

Dosage Studied

ExcerptRelevanceReference
" The aim of this study was to evaluate the depletion of florfenicol and its major metabolite, florfenicol amine, from the edible tissue of two fish species, rainbow trout and sea bream, following treatment with medicated feed at a dosage of 10 mg kg(-1) of bw day(-1) , for 10 consecutive days."( Florfenicol depletion in edible tissue of rainbow trout, Oncorhynchus mykiss (Walbaum), and sea bream, Sparus aurata L.
della Rocca, G; Di Salvo, A; Malvisi, J; Terzetti, E, 2013
)
0.61
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (38)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (2.63)18.2507
2000's8 (21.05)29.6817
2010's22 (57.89)24.3611
2020's7 (18.42)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.32

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.32 (24.57)
Research Supply Index3.87 (2.92)
Research Growth Index5.55 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.32)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (6.82%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other41 (93.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]